Pure Global: Brazil's MedTech Renewal Riddle - Cracking ANVISA's New 10-Year Cycle. episode artwork

EPISODE · Apr 20, 2026 · 2 MIN

Pure Global: Brazil's MedTech Renewal Riddle - Cracking ANVISA's New 10-Year Cycle.

from LATAM MedTech Insights

This week on LATAM MedTech Insights, we dissect a game-changing update from Brazil's regulatory agency, ANVISA. The validity for medical device registrations has been doubled from five to ten years. This sounds like great news, but it comes with a significant new hurdle: a mandatory mid-cycle compliance review that could catch unprepared companies off guard. We break down what this shift means for your long-term strategy in Latin America's biggest market. We explore the opportunities for reduced administrative burden and the hidden risks associated with the new, more stringent post-market surveillance requirements that underpin this extended registration period. Imagine your Class III device registration in Brazil is suddenly suspended five years into its new ten-year term. Your sales are frozen. This is the risk for manufacturers who misunderstand the new mid-cycle review. We discuss how to avoid this scenario by implementing a proactive compliance strategy from day one. Key Takeaways: - What specific documentation is required for ANVISA's new mid-cycle review? - How does the 10-year registration impact the role and responsibilities of a local Brazilian Registration Holder? - What are the biggest mistakes foreign manufacturers can make when adapting to this new regulation? - How should your Quality Management System be updated to handle continuous surveillance versus periodic renewal? - Does this change signal a wider trend towards longer registration cycles in other LATAM markets? - What are the specific post-market surveillance data points ANVISA will now scrutinize more closely? - How can you leverage this regulatory change to gain a competitive advantage in Brazil? At Pure Global, we provide the local expertise and strategic guidance to navigate these complex regulatory shifts. We offer end-to-end solutions, from initial market access strategy and technical dossier submission to managing your post-market surveillance and acting as your official in-country representative. To secure your market presence in Brazil and beyond, contact us at [email protected] or visit https://pureglobal.com/.

Episode metadata supplied by the publisher feed · Published Apr 20, 2026

Embed this episode

NOW PLAYING

Pure Global: Brazil's MedTech Renewal Riddle - Cracking ANVISA's New 10-Year Cycle.

0:00 2:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of LATAM MedTech Insights?

This episode is 2 minutes long.

When was this LATAM MedTech Insights episode published?

This episode was published on April 20, 2026.

Can I download this LATAM MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!